4//SEC Filing
Jones Edward Raymond 4
Accession 0001144204-18-022968
CIK 0001175151other
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 11:41 AM ET
Size
7.9 KB
Accession
0001144204-18-022968
Insider Transaction Report
Form 4
Jones Edward Raymond
Director
Transactions
- Award
Common Stock
2018-03-15+3,300→ 71,800 total - Award
Stock Option (right to buy)
2018-03-15+14,450→ 14,450 totalExercise: $7.90Exp: 2028-03-15→ Common Stock (14,450 underlying)
Footnotes (3)
- [F1]These shares represent restricted stock units and will be settled into common stock upon vesting upon a "Change in Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan").
- [F2]Includes (a) the following restricted stock units subject to vesting in accordance with the schedule set forth in (1) above: (i) 3,300 restricted stock units granted on March 15, 2018 and reported on this Form 4, (ii) 6,000 restricted stock units granted on February 24, 2017, (iii) 5,000 restricted stock units granted on June 7, 2016, and (iv) 55,000 restricted stock units granted on April 8, 2015, and (b) 2,500 shares of common stock owned by the reporting person.
- [F3]Such options were granted pursuant to the Plan and vest in four equal parts at the end of each calendar quarter beginning January 1, 2018.
Documents
Issuer
Cytosorbents Corp
CIK 0001175151
Entity typeother
Related Parties
1- filerCIK 0001396246
Filing Metadata
- Form type
- 4
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 11:41 AM ET
- Size
- 7.9 KB